Geode Capital Management
BIO icon

Geode Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$80.6M Sell
334,137
-8,806
-3% -$2.13M 0.01% 1152
2025
Q1
$83.4M Buy
342,943
+20,966
+7% +$5.1M 0.01% 1077
2024
Q4
$106M Sell
321,977
-1,931
-0.6% -$633K 0.01% 963
2024
Q3
$108M Sell
323,908
-154,930
-32% -$51.7M 0.01% 943
2024
Q2
$130M Buy
478,838
+5,637
+1% +$1.54M 0.01% 767
2024
Q1
$163M Buy
473,201
+13,115
+3% +$4.52M 0.02% 675
2023
Q4
$148M Buy
460,086
+7,984
+2% +$2.57M 0.02% 661
2023
Q3
$162M Buy
452,102
+1,381
+0.3% +$494K 0.02% 585
2023
Q2
$170M Buy
450,721
+5,817
+1% +$2.2M 0.02% 568
2023
Q1
$213M Buy
444,904
+10,018
+2% +$4.79M 0.03% 503
2022
Q4
$183M Buy
434,886
+7,721
+2% +$3.24M 0.03% 524
2022
Q3
$178M Sell
427,165
-12,347
-3% -$5.14M 0.03% 511
2022
Q2
$217M Buy
439,512
+390
+0.1% +$193K 0.03% 474
2022
Q1
$247M Buy
439,122
+12,499
+3% +$7.03M 0.03% 495
2021
Q4
$322M Sell
426,623
-822
-0.2% -$620K 0.04% 427
2021
Q3
$318M Buy
427,445
+36,170
+9% +$26.9M 0.04% 408
2021
Q2
$251M Buy
391,275
+13,591
+4% +$8.73M 0.03% 462
2021
Q1
$215M Buy
377,684
+21,546
+6% +$12.3M 0.03% 483
2020
Q4
$207M Buy
356,138
+7,926
+2% +$4.61M 0.03% 451
2020
Q3
$179M Buy
348,212
+2,498
+0.7% +$1.28M 0.04% 438
2020
Q2
$156M Buy
345,714
+96,777
+39% +$43.6M 0.03% 449
2020
Q1
$87.2M Buy
248,937
+5,951
+2% +$2.08M 0.02% 546
2019
Q4
$89.8M Buy
242,986
+12,340
+5% +$4.56M 0.02% 653
2019
Q3
$76.7M Buy
230,646
+14,664
+7% +$4.88M 0.02% 679
2019
Q2
$67.5M Sell
215,982
-7,822
-3% -$2.45M 0.02% 731
2019
Q1
$68.4M Buy
223,804
+9,616
+4% +$2.94M 0.02% 693
2018
Q4
$49.7M Buy
214,188
+15,557
+8% +$3.61M 0.02% 739
2018
Q3
$62.2M Buy
198,631
+13,680
+7% +$4.28M 0.02% 702
2018
Q2
$53.4M Buy
184,951
+8,250
+5% +$2.38M 0.02% 731
2018
Q1
$44.2M Sell
176,701
-3,400
-2% -$850K 0.01% 795
2017
Q4
$43M Buy
180,101
+5,819
+3% +$1.39M 0.01% 781
2017
Q3
$38.7M Buy
174,282
+2,534
+1% +$563K 0.01% 799
2017
Q2
$38.9M Buy
171,748
+11,337
+7% +$2.57M 0.02% 768
2017
Q1
$32M Buy
160,411
+11,711
+8% +$2.33M 0.01% 850
2016
Q4
$27.1M Buy
148,700
+3,982
+3% +$726K 0.01% 888
2016
Q3
$23.7M Buy
144,718
+9,292
+7% +$1.52M 0.01% 894
2016
Q2
$19.4M Buy
135,426
+5,401
+4% +$772K 0.01% 970
2016
Q1
$17.8K Buy
130,025
+4,121
+3% +$563 0.01% 997
2015
Q4
$17.5M Buy
125,904
+92
+0.1% +$12.8K 0.01% 983
2015
Q3
$16.9M Buy
125,812
+4,577
+4% +$615K 0.01% 978
2015
Q2
$18.3M Buy
121,235
+4,255
+4% +$641K 0.01% 985
2015
Q1
$15.8M Buy
116,980
+9,538
+9% +$1.29M 0.01% 1063
2014
Q4
$13M Buy
107,442
+642
+0.6% +$77.4K 0.01% 1133
2014
Q3
$12.1M Buy
106,800
+369
+0.3% +$41.8K 0.01% 1117
2014
Q2
$12.7M Sell
106,431
-493
-0.5% -$59K 0.01% 1117
2014
Q1
$13.7M Buy
106,924
+7,818
+8% +$1M 0.01% 1032
2013
Q4
$12.3M Buy
99,106
+11,111
+13% +$1.37M 0.01% 1053
2013
Q3
$10.3M Buy
87,995
+4,008
+5% +$471K 0.01% 1043
2013
Q2
$9.42M Buy
+83,987
New +$9.42M 0.01% 987